FDA Investigator Yiyue Zhang (nmi), PhD

Yiyue Zhang (nmi), PhD has conducted inspections on 31 sites in 1 countries as of 16 Oct 2023. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
31
Last Inspection Date:
16 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Yiyue Zhang (nmi), PhD:
Adetutu M Gidado, Aimee J Edwin, Alan M Barker, Alan P Kurtzberg, Amanda E Lewin, PhD, Amanda Jones, Amy N Chen, Andrea S Heise, Andrew W Harmon, Angel K Sandhu, Anh M Lac, Anita R Michael, Anthony J Ladner, April L Young, Ashar P Parikh, Azza Talaat, Barbara I Rogolsky, Barbara M Frazier, Bei Y He, Benton M Ketron, Betsy C Galliher, Bonita S Chester, Bradley J Maunder, Brooke K Higgins, Bruce H Mccullough, Candace Y Gomez Broughton, Carl A Huffman, III, Carl J Montgomery, Carl Lee, Carlos Chavez, Carolyn A Renshaw, CDR Rochelle B Young, RPh, MSA, CDR Thomas R Berry, PPh, Charles R Cote, RIC, Cheryl A Grandinetti, Chilton L Ng, Chris A Sack, Christina A Miller, Christopher M Jenner, Claudette D Brooks, Clinton D Priestley, Colleen E Burke, Courtney R Tiegs, Craig A Garmendia, Craig D Zagata, Craig T Rybus, Cynthia L Evitt, Cynthia M Goudeau, Dacia E Quick, Dale A Nyberg, David J Eide, David M Mcnew, Debra I Love, Debra Lboyd Seale, Denise L Burosh, Denise M Digiulio, Derrionna M Epps, Dianne H Milazzo, Dongping Dai, PhD, Dorothy J Denes, Dr. Abhijit Raha, PhD, Dr. Mark J Seaton, PhD, Dr. Sriram Subramaniam, PhD, Dr. Zhou Chen (nmi), MD PhD, Dustin K Hampton, Dustin M James, Dustin P Tran, Edith M Gonzalez, Eileen A Liu, Elaine E Gilfillan, Emest F Bizjak, Emily J Orban, Emmanuel Adu Gyamfi, PhD, Eric C Nielsen, Eric M Mueller, PharmD, Eric M Padgett, Eric S Pittman, Erika V Butler, Ernest H Blackwood, Fannie M Harrell, Farhana Khan, Felix Maldonado, Frank Wackes, Frederick M Lochner, Gabriel Davila, Gabriel R Mclemore, Gary T Greco, Geoffrey K Kilili, George C Amedro, George Ivan Wey, Ginger M Sykes, Gloria J Champagne, Gregory W Smith, Gretchen Lf Trendel, Hai Lient Phung, Hasan A Irier, PhD, Henry K Lau, Himanshu Gupta, PhD, Hugh M Mcclure, II, Hung H Do, MS, Ibad U Khan, Jagan Mohanr Parepally, PhD, James I Giefer, Jamie L Dion, Jane E Nelson, Janet L Bowen, Janete F Guardia, Jared P Stevens, Jason F Chancey, Jeanne J Thai, Jeffrey A Sommers, Jeffrey M Watson, Jennifer A Longie Vollom, Jennifer Al Vollon, Jesse A Vazquez, Jessica E Hensley, Jessica L Peterson, Jill J Tillman, Joan M Cantellops Figueroa, Joanne M Schlossin, Johnna L Bleem, Jolanna A Norton, Jonathan G Swoboda, Jonathan R Campos, Joseph A Piechocki, Joseph L Despins, PhD, Joseph R Lambert, Joslyn K Brunelle, PhD, Julie N Vosilus, Jyoti B Patel, PhD, Kara A Scheibner, PhD, Karen C Daugherty, Karen L Kosar, Karen M Kondas, Karen M Montgomery (KMM), Kellia N Hicks, Kerun Hardeo, Kevin A Swiss, PhD, Kevin P Foley, Kevin P Regan, Kimberley A Hoefen, Kula N Jha, Lance Mde Souza, MBA, Larry K Austin, Larry K Hampton, Latonya M Mitchell, Laura Fontan, MS, Laura L Staples, Lauren L Vajo, Lauren N Howard, LCDR Chad N Thompson, LCDR Ismael Olvera, IV, Lequita M Mayhew, Lillie D Witcher, Linda F Murphy, Linda R Kuchenthal, Lisa Hornback, Logan T Williams, Loretta Nemchik, Lori A Gioia, LT John M Mastalski, Makini Cobourne Duval, PhD, Marcellinus D Dordunoo, Marcelo O Mangalindan, Jr, Marcia A Worley, Margaret E Sarles, Margaret M Annes, Marie A Fadden, Marion W Nadeau, Mark W Babbitt, Mary E Storch, Matthew M Schuckmann, Matthew R Dionne, Matthew Schuckman, Mei Ou, Meisha Waters, Melissa I Michurski, Melkamu Getie Kebtie, PhD, Michael A Charles, Michael C Zubelewicz, Michael F Skelly, PhD, Michael G Sinkevich, Michael J Kuchta, Michael L Casner, Michael R Goga, Michael Serrano, Michele L Obert, Michele Perry Williams, Mike M Rashti, Mohsen Rajabi Abhari, FDA, Monica E Murie, Nayan J Patel, Neal D Singletary, PhD, Nicholas C Mendiola, Nicholas P Diorio, Nicholas Z Lu, Nicole C Victoria, PhD, Nicole S Williams, Nilufer M Tampal, PhD, Pamela L Velez Vega, Patricia S Smith, Patrick L Wisor, Paula A Trost, Penny H Mccarver, Prabhu P Raju, Rachael L Cook, Rafael Padilla, Raymond T Oji, Reba A Gates, Richard W Berning, Ricki A Chase, Rita K Kabaso, Robert J Ham, Robert M Barbosa, Rodney D Combs, Rose Ljean Mary, Ross J Grigsby, Ruben C Ayala, PharmD, Russ E Davis, Russell K Riley, Sam Pepe, Samuel H Chan, PharmD, Sandra A Hughes, Santos E Camara, Scott A Golladay, Seongeun Cho (Julia), PhD, Shalonda C Clifford, Sharon K Thoma, PharmD, Sharon L Matson, Sherri J Jackson, Sri Ramakrishnaiah Yellela, PhD, Srinivas R Chennamaneni, PhD, Sripal R Mada, PhD, Stephanie Mangigian, MS/OSH, RN, Stephen J Kilker, Stephen T Hansen, Susan D Yuscius, Susanna E Ford, Tara L Greene, Tara L King, Tekalign Wondimu, Tenzin Jangchup, Thomas J Arista, Thomas R Withers, Thomas W Nojek, Timothy R Marrs, Todd J Maushart, Tracy R Ball, Uduak M Inokon, Uttaniti Limchumroon (Tom), Veronica Fuentes, MS, Vickie J Kanion, Victoria P Quadrini, Vikas Moolchandani, Wayne D Mcgrath, William V Millar, Xiaohan Cai, PhD, Xikui Chen (nmi), PhD, Ying Xin Fan, PhD, Yiying E Chen, Yuanyuan Li, Yvins Dezan, Zachary A Bogorad, Zachary L Miller

Yiyue Zhang (nmi), PhD's Documents

Publish Date Document Type Title
April, 2019 EIR The Ritedose Corporation - EIR, 2019-04-18
November, 2019 EIR ICON Development Solutions, LLC - EIR, 2019-11-22
June, 2016 FDA 483 Integris Bioservices LLC - Form 483, 2016-06-24
June, 2018 EIR Q2 Solutions - EIR, 2018-06-29
December, 2017 FDA 483 Celerion, Inc - Form 483, 2017-12-08
April, 2019 FDA 483 The Ritedose Corporation - Form 483, 2019-04-18
February, 2019 EIR AbbVie Inc. - EIR, 2019-02-15
November, 2018 EIR BioMarin Pharmaceutical Inc. - EIR, 2018-11-09
July, 2017 EIR Charles River Laboratories Ashland, LLC - EIR, 2017-07-21
April, 2019 FDA 483 Response The Ritedose Corporation - Form 483R, 2019-05-03
August, 2019 EIR OpAns, LLC - EIR, 2019-08-16
March, 2018 EIR Frontage Laboratories, Inc. - EIR, 2018-03-08
October, 2023 FDA 483 Integris Bioservices LLC - Form 483, 2023-10-20
June, 2016 EIR Integris Bioservices LLC - EIR, 2016-06-24
October, 2019 EIR Astellas Pharma US Inc. - EIR, 2019-10-04
October, 2019 FDA 483 Response Astellas Pharma US Inc. - Form 483R, 2019-10-24
August, 2017 FDA 483 Hi-Tech Pharmacal Co. Inc. - Form 483, 2017-08-04
July, 2017 FDA 483 Response Charles River Laboratories Ashland, LLC - Form 483R, 2017-08-10
July, 2017 FDA 483 Charles River Laboratories Ashland, LLC - Form 483, 2017-07-21
October, 2015 EIR Xenobiotic Laboratories, Inc. - EIR, 2017-11-07
December, 2024 EIR Smithers Pharmaceutical Development Services - EIR, 2025-01-21
March, 2017 FDA 483 Microconstants Inc (DBA BioAgilytix Labs, LLC) - Form 483, 2017-03-03

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more